Pill Imprint M C17
This white round pill with imprint M C17 on it has been identified as: Bicalutamide 50 mg.
This medicine is known as bicalutamide. It is available as a prescription only medicine and is commonly used for Prostate Cancer.
Details for pill imprint M C17
- Drug
- Bicalutamide
- Imprint
- M C17
- Strength
- 50 mg
- Color
- White
- Shape
- Round
- Size
- 6mm
- Availability
- Prescription only
Pill Classification
- National Drug Code (NDC)
- 003787017 - Mylan Pharmaceuticals Inc.
Read this next
-
Is A Universal Cancer Treatment On The Horizon?
The discovery of a new type of T cell could lead to the development of a therapy that may treat all cancers
-
Prostate Cancer Treatments: Exploring the Options
Treatment options range from more traditional cancer therapies like surgery, radiation and chemotherapy to cutting-edge hormone and biological therapies
-
The 4 stages of prostate cancer
Prostate cancer staging is used to describe the extent of the cancer and helps determine treatment options, prognosis and more.
-
Stage 4 Prostate Cancer: Survival Rates, Treatment and Support
Stage 4 is an advanced stage of prostate cancer, but treatment options are available to improve quality of life and slow the disease
